Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults

Clinical trial NCT05817422 · COMPLETED

Trial details

NCT number: NCT05817422
Sponsor: Albert B. Sabin Vaccine Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Marburg Virus Disease

Start date: 2023-10-19
Primary completion: 2025-04-25
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.